血清干细胞衍生因子1α作为急性髓性白血病的老年患者接受CAG化疗的预后指标

Zhenzhen Wang1, Jing Yuan1, Nan Zhou1

  • 1Department of Hematology, the Second Hospital of Hebei Medical University, Hebei, Shijiazhuang, China.

Frontiers in oncology
|January 28, 2025
PubMed
概括

在老年急性髓性白血病 (AML) 患者中,肌细胞衍生因子1 (SDF-1) 的升高与化疗反应不佳和生存率降低相关. SDF-1可以作为治疗结果的预后生物标志物.